PCC Rokita SA (WSE:PCR)

Market Cap	1.33B -1.4%
Revenue (ttm)	1.79B -6.2%
Net Income	132.55M +26.0%
EPS	6.59 +24.3%
Shares Out	20.26M
PE Ratio	9.97
Forward PE	10.54
Dividend	2.65 (4.07%)
Ex-Dividend Date	Apr 24, 2026

Volume	12,599
Open	65.70
Previous Close	65.70
Day's Range	64.90 - 66.70
52-Week Range	58.40 - 74.40
Beta	0.58
Analysts	Buy
Price Target	78.27 (+20.23%)
Earnings Date	Nov 10, 2026

About PCC Rokita

PCC Rokita SA designs, produces, and sells chemical products in Poland, Germany, the European Union, rest of Europe, the United States, Asia, and internationally. It operates through five segments: Polyurethanes, Chlorine Derivatives, Other Chemical Activities, Energy, and Other Activities. The Polyurethanes segment produces polyols, polyurethane systems, and prepolymers; and flexible foams, rigid foams, coatings, elastomers, adhesives, impregnations, and other products. The Chlorine Derivatives segment provides chlorine, sodium hydroxide, caus...

• Industry: Chemicals
• Sector: Materials
• Founded: 2002
• Employees: 1,662
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: PCR

Financial Performance

In 2025, PCC Rokita's revenue was 1.80 billion, a decrease of -7.50% compared to the previous year's 1.95 billion. Earnings were 61.48 million, a decrease of -57.02%.

Analyst Summary

According to 3 analysts, the average rating for PCR stock is "Buy." The 12-month stock price target is zł 78.27, which is an increase of 20.23% from the latest price.

Price Target

zł 78.27

(20.23% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 30, 2026

Data Sources Report a data error